Diagnostic Accuracy of Alpha-Methylacyl-CoA Racemase Immunohistochemical Expression for the Diagnosis of Ovarian and Endometrial Clear Cell Carcinomas

سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 98

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJP-18-1_006

تاریخ نمایه سازی: 26 اردیبهشت 1402

چکیده مقاله:

Background & Objective: Clear cell carcinoma (CCC) is an uncommon histopathologic subtype of ovarian and endometrial carcinoma. Due to the morphologic overlapping with other subtypes of ovarian and endometrial carcinomas, an accurate diagnosis is crucial.Methods: In this study, ۳۱ cases of ovarian clear cell carcinoma (OCCC), ۲۸ endometrial clear cell carcinoma (ECCC), and ۸۰ non-CCC subtypes (۳۳ high-grade serous carcinomas of the ovary, ۲ low-grade serous carcinomas, ۱۰ ovarian endometrioid, ۳ serous carcinomas and ۲۹ endometrioid carcinomas of the endometrium) were investigated for immunohistochemical expression of AMACR. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for the distinction of OCCC and ECCC from other histopathologic subtypes were calculated.Results: Positive AMACR staining was seen in ۱۸ OCCCs (۵۸%) and ۱۰ ECCCs (۳۵.۷%). In the non-clear cell group, ۴۴ cases of ovarian (۹۸%) and ۲۵ cases of endometrial carcinoma (۷۸%) showed negative results. Only one case of ovarian endometrioid carcinoma and ۷ cases (۲۲%) of endometrial endometrioid carcinomas revealed a positive reaction (P<۰.۰۵). Collectively, sensitivity, specificity, PPV, and NPV of AMACR expression, for the diagnosis of OCCC were calculated as  ۵۸%, ۹۸%, ۹۴.۷%, and ۷۷.۲%, respectively. The sensitivity, specificity, PPV, and NPV were shown to be as  ۳۵.۷%, ۷۸.۱%, ۵۸.۸%, and ۵۸.۱%, respectively in the endometrium.Conclusion: AMACR may be  a highly specific immunohistochemical marker for the distinction of serous and clear cell carcinoma. A small percentage of endometrioid carcinoma may show positive staining. The sensitivity of this marker may not be higher than the other well-known Napsin-A IHC marker.

نویسندگان

Fatemeh Nili

Department of Pathology, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

Soheib Fathi

Department of Pathology, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

Mansoureh Tavakoli

Department of Pathology, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

Elham Mirzaian

Department of Pathology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran

Maryam Lotfi

Department of Pathology, Amir-Alam Hospital, Tehran University of Medical Sciences, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Gadducci A, Multinu F, Cosio S, Carinelli S, Ghioni M, ...
  • Gaona-Luviano P, Medina-Gaona LA, Magana-Perez K. Epidemiology of ovarian cancer. ...
  • Rekhi B, Deodhar KK, Menon S, Maheshwari A, Bajpai J, ...
  • Soslow RA. High‐grade endometrial carcinomas-strategies for typing. Histopathology. ۲۰۱۳;۶۲(۱):۸۹-۱۱۰. [DOI:۱۰.۱۱۱۱/his.۱۲۰۲۹] ...
  • نمایش کامل مراجع